|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
$38,164
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-09S3
|
$1,375,035
|
$13,750
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-09
|
$26,766,352
|
$267,664
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-09
|
$5,780,843
|
$57,808
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Pediatric Brain Tumor Consortium (PBTC)
|
5U01CA081457-13
|
$2,220,171
|
$1,287,699
|
BOYETT, JAMES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
North Central Cancer Treatment Group
|
3U10CA025224-32S1
|
$1,347,651
|
$13,477
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
North Central Cancer Treatment Group
|
5U10CA025224-32
|
$5,018,658
|
$50,187
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
$184,156
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$489,703
|
$48,970
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$489,703
|
$24,485
|
Daar, Ira
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA013696-38S1
|
$74,998
|
$750
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S2
|
$139,995
|
$1,400
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-33S3
|
$75,000
|
$7,500
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,547,976
|
$509,595
|
Fine, Howard
|
CCR (NCI)
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA021765-33
|
$5,674,815
|
$567,482
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$548,663
|
$27,433
|
Gottesman, Michael
|
CCR (NCI)
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-24
|
$238,542
|
$59,636
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
N01CO800001-038
|
$221,493,424
|
$218
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$48,425
|
$4,842
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Statistical Inference on Chemotherapy Effects from Flow Cytometry Data
|
5R01CA134839-04
|
$227,432
|
$113,716
|
Hyrien, Ollivier
|
UNIVERSITY OF ROCHESTER
|
|
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
|
4R01CA129182-03
|
$439,902
|
$109,976
|
Jackson, Andrew
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
ATM, REACTIVE OXYGEN, AND CELLULAR RESPONSES TO HYPOXIA
|
1R01CA157216-01
|
$288,425
|
$288,425
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-33S1
|
$126,000
|
$12,600
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-33S2
|
$50,000
|
$5,000
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pediatric Cancer, Family Conflict and Child Adjustment
|
5R01CA134794-02
|
$341,099
|
$85,275
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$322,491
|
$96,747
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$881,476
|
$44,073
|
Khan, Javed
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$107,497
|
$5,374
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$214,994
|
$42,998
|
Khan, Javed
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$420,341
|
$21,017
|
Kleiner, David
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,420,622
|
$71,031
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Sulfatide-reactive type II NKT cells: repertoire and function
|
5R01CA100660-07
|
$349,565
|
$349,565
|
Kumar, Vipin
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-21S1
|
$50,000
|
$500
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-21
|
$321,790
|
$3,218
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$552,204
|
$27,610
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,104,407
|
$55,220
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$828,305
|
$82,830
|
Linehan, W. Marston
|
CCR (NCI)
|
|
RNA interference approach to dissect roles of notochord regulators
|
ZIA BC 011121
|
$80,056
|
$24,016
|
Mackem, Susan
|
CCR (NCI)
|
|
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
|
5R01CA122617-06
|
$258,308
|
$258,308
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
3U54CA151880-02S1
|
$57,724
|
$3,463
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Nanomaterials for Cancer Diagnostics and Therapeutics
|
5U54CA151880-02
|
$2,329,637
|
$139,778
|
MIRKIN, CHAD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
CNS vulnerability to systemic chemotherapy: Causes and prevention
|
5R01CA131385-04
|
$309,964
|
$309,964
|
NOBLE, MARK
|
UNIVERSITY OF ROCHESTER
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIA BC 010440
|
$475,236
|
$33,266
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Consequences of receptor cross talk on inflammation and algesia
|
ZIA BC 010708
|
$56,648
|
$22,659
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Mechanisms of ATM activation
|
5R01CA132813-03
|
$242,941
|
$242,941
|
PAULL, TANYA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-10
|
$1,464,654
|
$14,647
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Pediatric Clinical Oncology Research Training Program
|
3K12CA090433-10S1
|
$134,042
|
$53,617
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-10
|
$475,607
|
$190,243
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$644,844
|
$64,484
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIA BC 010540
|
$184,241
|
$64,484
|
Reilly, Karlyne
|
CCR (NCI)
|
Total relevant funding to Central Nervous System - Not Including Brain for this search: $7,473,242
|